| UNITED STATES  | |||||||||||||||||
| SECURITIES AND EXCHANGE COMMISSION | |||||||||||||||||
| Washington, D.C. 20549 | |||||||||||||||||
| SCHEDULE 14A | |||||||||||||||||
| Proxy Statement Pursuant to Section 14(a) of the  | |||||||||||||||||
| Securities Exchange Act of 1934  | |||||||||||||||||
| Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ | |||||||||||||||||
| Check the appropriate box:  | |||||||||||||||||
| ☐ | Preliminary Proxy Statement | ||||||||||||||||
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||||||||||||||||
| ☐ | Definitive Proxy Statement | ||||||||||||||||
| ☒ | Definitive Additional Materials | ||||||||||||||||
| ☐ | Soliciting Material under §240.14a-12 | ||||||||||||||||
| LIANBIO  | |||||||||||||||||
| (Name of Registrant as Specified in Its Charter) | |||||||||||||||||
| (Name of Person(s) Filing Proxy Statement if other than Registrant) | |||||||||||||||||
|  Payment of Filing Fee (Check the appropriate box):  | |||||||||||||||||
| ☒ | No fee required. | ||||||||||||||||
| ☐ | Fee paid previously with preliminary materials. | ||||||||||||||||
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 | ||||||||||||||||

